Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Oncternal Therapeutics, Inc.c24158exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2011
GTx, Inc.
(Exact name of registrant as specified in its charter)
         
Delaware   000-50549   62-1715807
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
175 Toyota Plaza 7th Floor
Memphis, Tennessee
   
38103
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (901) 523-9700
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

ITEM 2.02 Results of Operations and Financial Condition.
On November 4, 2011, GTx, Inc. issued an earnings release for the third quarter ended September 30, 2011, a copy of which is furnished as Exhibit 99.1 to this Current Report.
This release is furnished by GTx pursuant to Item 2.02 of Form 8-K and is not to be considered “filed” under the Exchange Act, and shall not be incorporated by reference into any previous or future filing by the Registrant under the Securities Act or the Exchange Act.
ITEM 9.01 Financial Statements and Exhibits.
(c) Exhibits
         
Exhibit    
Number   Description
  99.1    
Press Release issued by GTx, Inc. dated November 4, 2011

 

 


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  GTx, INC.
 
 
Date: November 4, 2011  By:   /s/ Mark E. Mosteller    
    Name:   Mark E. Mosteller   
    Title:   Vice President and Chief Financial Officer
(principal accounting and financial officer)